Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY48.47 CNY
Change Today +2.37 / 5.14%
Volume 15.4M
As of 3:05 AM 04/1/15 All times are local (Market data is delayed by at least 15 minutes).

jiangsu hengrui medicine c-a (600276) Snapshot

Open
CNY46.09
Previous Close
CNY46.10
Day High
CNY49.18
Day Low
CNY45.98
52 Week High
04/1/15 - CNY49.18
52 Week Low
07/28/14 - CNY29.06
Market Cap
72.9B
Average Volume 10 Days
13.1M
EPS TTM
CNY1.03
Shares Outstanding
1.5B
EX-Date
--
P/E TM
47.3x
Dividend
CNY0.10
Dividend Yield
0.17%
Current Stock Chart for JIANGSU HENGRUI MEDICINE C-A (600276)

Related News

No related news articles were found.

jiangsu hengrui medicine c-a (600276) Related Businessweek News

No Related Businessweek News Found

jiangsu hengrui medicine c-a (600276) Details

Jiangsu Hengrui Medicine Co., Ltd. manufactures and distributes pharmaceutical products in China. It offers antineoplastic, angiomyocardiac, antibiotic, Apis, and other drugs in the form of tablets, injectables, injections, oral solutions, capsules, and ointments. The company was founded in 1970 and is headquartered in Lianyungang, China.

Founded in 1970

jiangsu hengrui medicine c-a (600276) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

jiangsu hengrui medicine c-a (600276) Key Developments

Jiangsu Hengrui Medicine Co., Ltd. Reports Earnings Results for the Full Year of 2014

Jiangsu Hengrui Medicine Co., Ltd. reported earnings results for the full year of 2014. For the year, the company reported basic earnings per share of CNY 1.01 and weighted average return on net assets of 21.28%.

Jiangsu Hengrui Medicine Co., Ltd., Board Meeting, Mar 27, 2015

Jiangsu Hengrui Medicine Co., Ltd., Board Meeting, Mar 27, 2015. Agenda: To discuss and approve the annual report of 2014 and it’s abstract; to consider the profit distribution scheme for 2014; and to consider the proposal of prediction on daily connected transactions in 2015.

Jiangsu Hengrui Medicine Co., Ltd. Presents at China Healthcare Investment Conference - Shanghai, Apr-01-2015 03:00 PM

Jiangsu Hengrui Medicine Co., Ltd. Presents at China Healthcare Investment Conference - Shanghai, Apr-01-2015 03:00 PM. Venue: Shangri-La Pudong Hotel, 33 Fu Cheng Road, Pudong, Shanghai 200120, China. Speakers: Lianshan Zhang, President of Global R&D.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600276:CH CNY48.47 CNY +2.37

600276 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600276.
View Industry Companies
 

Industry Analysis

600276

Industry Average

Valuation 600276 Industry Range
Price/Earnings 47.7x
Price/Sales 9.6x
Price/Book 9.1x
Price/Cash Flow 48.0x
TEV/Sales 9.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JIANGSU HENGRUI MEDICINE C-A, please visit www.hrs.com.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.